(Q36986515)

17 August 2017

1 reference

title

Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics (English)

1 reference

17 August 2017

1 reference

Poland GA

1

1 reference

17 August 2017

Ovsyannikova IG

series ordinal

2

1 reference

17 August 2017

Jacobson RM

series ordinal

3

1 reference

17 August 2017

Smith DI

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

31 October 2007

1 reference

Clinical Pharmacology & Therapeutics

17 August 2017

1 reference

17 August 2017

82

1 reference

17 August 2017

653-664

1 reference

17 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100415

17 August 2017

0 references

cites work

Genetic variation in human disease and a new role for copy number variants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Balanced polymorphism selected by genetic versus infectious human disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The genomics and genetics of human infectious disease susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The genetic basis for variation in antibody response to vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Twin studies of immunogenicity--determining the genetic contribution to vaccine failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Studies of twins in vaccinology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Genetic regulation of immune responses to vaccines in early life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Hunting for immune response regulatory genes: vaccination studies in infant twins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The major histocompatibility complex haplotypes dictate and the background genes fine-tune the dominant versus the cryptic response profile of a T-cell determinant within a native antigen: relevance to disease susceptibility and vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The association between HLA class I alleles and measles vaccine-induced antibody response: evidence of a significant association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Variation in vaccine response in normal populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The association of class I HLA alleles and antibody levels after a single dose of measles vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Identification of an association between HLA class II alleles and low antibody levels after measles immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The contribution of HLA class I antigens in immune status following two doses of rubella vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Human Leukocyte Antigen Class II Alleles and Rubella‐Specific Humoral and Cell‐Mediated Immunity following Measles‐Mumps‐Rubella–II Vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Human genetics and responses to influenza vaccination: clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Genetic prediction of nonresponse to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Response to hepatitis B vaccine: multiple HLA genes are involved.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

HLA supertypes and supermotifs: a functional perspective on HLA polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Associations between Human Leukocyte Antigen Homozygosity and Antibody Levels to Measles Vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Human leukocyte antigen and interleukin 2, 10 and 12p40 cytokine responses to measles: is there evidence of the HLA effect?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

IL-12 and IL-10 polymorphisms and their effects on cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The immunogenetics of smallpox vaccination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Measles virus receptors: SLAM and CD46.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Viruses and Toll-like receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The role of Toll-like receptors in the host response to viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Susceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CDw150: role of Toll stimulators in DC maturation and MV amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

How the host 'sees' pathogens: global gene expression responses to infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Polymorphism in clinical immunology - From HLA typing to immunogenetic profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The extent and analysis of cytokine and cytokine receptor gene polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Phenotypic plasticity in the interactions and evolution of species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The evolutionary consequences of plasticity in host-pathogen interactions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The pharmacogenetics research network: from SNP discovery to clinical drug response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Genomewide linkage searches for Mendelian disease loci can be efficiently conducted using high-density SNP genotyping arrays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The Sequence of the Human Genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Initial sequencing and analysis of the human genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Genome sequencing in microfabricated high-density picolitre reactors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Immunogenicity of peptides of measles virus origin and influence of adjuvants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

IL-1Beta Gene Polymorphisms Influence Hepatitis B Vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Therapeutics and toxicology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Peptide-specific CTL induction in HBV-seropositive PBMC by stimulation with peptides in vitro: novel epitopes identified from chronic carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

The role of mass spectrometry in vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Identification of HLA-DRB1-bound self-peptides following measles virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100415

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100415

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference